Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron vs Ondansetron for RINV in GI Cancer
NCT00971399Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2009
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramosetron in radiotherapy-induced nausea and vomiting (RINV), sponsored by Seoul National University Hospital. Started Sep 2009; status: completed.
02
Drugs
ramosetron
03
Conditions
radiotherapy-induced nausea and vomiting (RINV)
Beyond the preview
Go deeper on NCT00971399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00971399.